•
China’s 2,168 Class 3 public hospitals demonstrated enhanced fiscal discipline in 2023, with medical services revenue rising 0.94 pp to 29.59%. Key cost-control measures drove reductions in auxiliary medication (-0.03 pp to 0.62%) and high-value consumables (-3.22 pp to 24.86%). Essential drug utilization improved, with inpatient adoption reaching 96.30% (+0.13…
•
The National Health Commission (NHC) will eliminate outpatient prepayment requirements across public medical institutions by March 31, 2025, marking a pivotal shift in China’s healthcare financing framework. Hospitals must complete refunds for existing prepayments by December 31, 2025. Concurrently, hospitalization advance payments will be reduced starting June 30, 2025, aligning…
•
The Pharmacopoeia of the People’s Republic of China (2025 Edition), released by the National Medical Products Administration and National Health Commission, has been approved by the 12th Conference of the Chinese Pharmacopoeia Commission (ChPC) Executive Committee. The new edition is scheduled for implementation on October 1, 2025. Regulatory RequirementsFrom the…
•
In a bid to bolster public health infrastructure and improve healthcare services, China’s National Health Commission (NHC), alongside the National Administration of Traditional Chinese Medicine and the National Disease Control and Prevention Administration, has unveiled its first batch of practical projects for 2024. These initiatives are part of a broader…
•
The Department of Maternal and Child Health Care of the National Healthcare Commission (NHC) has released the “Opinions on the Construction of Child-Friendly Hospitals,” setting a target for over 90% of medical institutions to become child-friendly by 2030. The initiative encourages grassroots medical and health institutions, such as township health…
•
The National Healthcare Security Administration (NHSA) and National Health Commission (NHC) of China have released the “Notice on Improving the Working Mechanism for Volume-based Procurement (VBP) and its Implementation.” The notice outlines refined measures for hospital access, use, monitoring, examination, and feedback in relation to VBP drugs and consumables. Urging…
•
The National Health Commission, in conjunction with three other bureaus, has issued the “Notice on Deepening Collaboration Agreements Between Medical/Health Institutions and Elderly Care Institutions.” This document outlines the requirements for cooperation between medical and health institutions and elderly care institutions, focusing on content, safety, mechanisms, and modes of collaboration.…
•
The National Health Commission (NHC) has released the “Pilot Work Plan for Expanding the Wholly Foreign-Owned Hospital Sector,” supported by the Ministry of Commerce (MOC), National Administration of Traditional Chinese Medicine, and National Bureau of Disease Control and Prevention. This policy aims to set specific requirements for the operation of…
•
The National Health Commission (NHC) has released a notification aimed at enhancing the continuity of medical services through the establishment of a robust first visit and referral system. The plan outlines a timeline for the development of a smooth two-way referral system within compact medical consortia, including urban medical groups…
•
The National Healthcare Commission (NHC) has issued the “Guiding Opinions on Further Promoting Mutual Recognition of Inspection and Testing Results in Medical Institutions,” a document designed to encourage the standardization and sharing of medical inspection results across China. Targets for Medical Consortia by 2025The NHC has set clear targets for…
•
The National Health Commission (NHC) has issued a set of opinions designed to accelerate the construction of a grassroots drug linkage management mechanism and to broaden the range of drugs used for chronic and common diseases in primary medical and health institutions. Provincial and Municipal Health Commissions’ Role in Drug…
•
The National Health Commission, National Administration of Traditional Chinese Medicine, and National Bureau of Disease Control and Prevention have jointly published the “Reference Guidelines for Artificial Intelligence (AI) Application Scenarios in the Healthcare Industry.” These guidelines provide a comprehensive framework for the integration of AI across various sectors within the…
•
The National Health Commission (NHC) has issued a notification aimed at enhancing gerontology medical service capabilities, outlining specific work requirements. These include the construction of geriatric medicine departments, development of geriatric medical talent teams, standardization of geriatric medical diagnosis and treatment services, and enrichment of service models. Improving Geriatric Medicine…
•
The Shanghai Municipal Health Commission, along with 13 other bureaus, has issued a local adaptation of the “Key Points for Correcting Unhealthy Practices in the Field of Pharmaceutical Procurement and Sales and Medical Services in 2024,” which was originally published by the National Health Commission (NHC) and supported by 14…
•
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control and Prevention Administration have issued a notification regarding the management measures for investigator-initiated trials (ITT) in medical and health institutions, effective from October 1. ITTs within these institutions are defined as activities with individuals or…
•
The National Healthcare Security Administration (NHSA), National Health Commission, and National Medical Products Administration (NMPA) have jointly issued guidelines aimed at establishing a medical insurance payment eligibility management system for personnel at designated medical institutions. This initiative pertains to individuals at such institutions who are involved with the use of…
•
The National Health Commission, Ministry of Finance, National Administration of Traditional Chinese Medicine, and National Disease Control and Prevention Administration in China have jointly issued a notification to enhance basic public health services for the current year. The subsidy standard for per capita funding for basic public health services will…
•
The National Health Commission (NHC) has issued a notification regarding the fifth batch of pediatric drugs encouraged for research and development. The list includes 15 varieties, encompassing systemic anti-infective drugs, respiratory system medications, anti-tumor drugs, and immune modulators. This edition features 25 specifications and 8 dosage forms, and is notable…
•
China’s Ministry of Commerce, National Health Commission, and National Medical Products Administration (NMPA) have jointly released a “Notification on Carrying out Pilot Work to Expand the Opening Up of the Medical Field,” signaling a significant shift in the country’s healthcare landscape. The notification outlines measures aimed at further opening up…
•
China’s National Health Commission (NHC), in collaboration with the National Development and Reform Commission, Ministry of Finance, and 10 other ministries, has unveiled the ‘Guiding Opinions on Promoting the Construction of Healthy Villages.’ The initiative sets an ambitious vision to substantially enhance the quality and accessibility of rural healthcare services…